IRIS UniCatt

Bellesi, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.996
EU - Europa 3.423
AS - Asia 3.240
SA - Sud America 601
AF - Africa 96
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.366
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.838
SG - Singapore 1.418
DE - Germania 1.067
CN - Cina 775
SE - Svezia 510
BR - Brasile 489
IT - Italia 468
VN - Vietnam 419
FR - Francia 317
PL - Polonia 221
GB - Regno Unito 191
FI - Finlandia 157
IN - India 126
UA - Ucraina 123
IE - Irlanda 112
CA - Canada 93
JP - Giappone 92
ID - Indonesia 82
RU - Federazione Russa 67
HK - Hong Kong 53
AR - Argentina 44
MX - Messico 42
NL - Olanda 34
BD - Bangladesh 33
TR - Turchia 33
AT - Austria 29
KR - Corea 28
IQ - Iraq 27
ZA - Sudafrica 23
TW - Taiwan 22
CI - Costa d'Avorio 21
CZ - Repubblica Ceca 21
BE - Belgio 20
SA - Arabia Saudita 16
MA - Marocco 15
VE - Venezuela 15
ES - Italia 14
PK - Pakistan 14
EC - Ecuador 13
IR - Iran 13
IL - Israele 12
UZ - Uzbekistan 11
CO - Colombia 10
JO - Giordania 9
LT - Lituania 9
PH - Filippine 9
PY - Paraguay 9
CL - Cile 8
GR - Grecia 8
KE - Kenya 8
CH - Svizzera 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
HN - Honduras 6
MY - Malesia 6
PT - Portogallo 6
TN - Tunisia 6
NP - Nepal 5
PE - Perù 5
RO - Romania 5
AL - Albania 4
BG - Bulgaria 4
EE - Estonia 4
HU - Ungheria 4
JM - Giamaica 4
KG - Kirghizistan 4
RS - Serbia 4
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
LB - Libano 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CG - Congo 2
CY - Cipro 2
KH - Cambogia 2
KZ - Kazakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EU - Europa 1
GY - Guiana 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 11.353
Salva come PNG Salva come JPEG
Città #
Singapore 833
Chandler 482
Ashburn 387
San Jose 355
Warsaw 202
Munich 173
Beijing 158
New York 124
Ho Chi Minh City 123
The Dalles 121
Fairfield 116
Hanoi 109
Dublin 108
Los Angeles 99
Rome 97
Hefei 94
Jacksonville 91
Helsinki 90
Houston 87
San Mateo 81
Lauterbourg 75
Jakarta 74
Tokyo 72
Wilmington 65
Nanjing 64
Dearborn 60
Frankfurt am Main 60
Ann Arbor 58
Seattle 56
Dallas 55
Woodbridge 54
Milan 52
Marseille 50
Nürnberg 50
Boston 47
Hong Kong 45
Moscow 44
São Paulo 41
Bremen 37
Cattolica 37
Chicago 37
Lancaster 35
Princeton 34
Buffalo 33
London 29
Nanchang 29
Council Bluffs 28
Montreal 28
Seoul 27
Nuremberg 26
Da Nang 25
Guangzhou 25
Kent 25
Santa Clara 25
Redwood City 24
Hyderabad 23
Toronto 22
Abidjan 21
Phoenix 21
Cambridge 20
Haiphong 20
Lappeenranta 20
Lawrence 20
Mexico City 20
Orem 20
Rio de Janeiro 20
Tianjin 20
Amsterdam 19
Atlanta 18
Boardman 18
Brussels 18
Paris 18
Brno 17
Brooklyn 17
Hangzhou 17
Turku 17
Johannesburg 16
Leawood 16
Shanghai 16
Vienna 16
Belo Horizonte 15
Denver 15
Poplar 15
Chennai 14
San Francisco 14
St Louis 14
Stockholm 14
Baghdad 12
Düsseldorf 12
Fremont 12
Manchester 12
Changsha 11
Izmir 11
Wroclaw 11
Kunming 10
Naples 10
Norwalk 10
Pune 10
Tashkent 10
Amman 9
Totale 6.167
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 341
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 329
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 285
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 269
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 240
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 238
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Correlation between paraproteinaemia and viral reactivation after allo-SCT 215
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 194
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 191
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 187
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 184
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 181
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 180
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 176
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 175
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 170
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 169
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 166
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 159
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 158
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 158
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 157
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 153
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 152
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 151
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 151
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 150
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 145
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 139
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 138
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 138
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 137
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 137
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 134
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 125
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 122
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 118
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 115
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 113
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 111
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 110
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 109
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 107
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 107
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 107
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 106
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 106
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 106
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 104
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 103
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 102
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 102
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 101
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 100
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 95
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 95
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 90
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 89
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 86
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 85
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 85
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 83
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 82
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 79
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 76
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 76
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 76
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 71
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 69
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 66
External validation of the accuracy of 'CLLflow score' 66
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 54
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements 40
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 37
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 29
Totale 11.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 143 28
2021/2022619 49 32 7 14 33 20 18 83 33 64 116 150
2022/20231.381 203 193 87 232 93 138 95 96 139 43 45 17
2023/2024738 33 181 28 41 26 100 54 54 10 29 86 96
2024/20252.019 65 61 118 101 169 108 145 92 241 185 405 329
2025/20264.248 582 156 262 504 797 211 886 231 267 286 66 0
Totale 11.541